Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
Neural Regen Res
.
2016 Jan;11(1):83-5.
doi: 10.4103/1673-5374.169632.
Authors
Natalie Hellmers
1
,
Yaa Obeng-Aduasare
1
,
Inmaculada de Melo-Martín
2
,
Claire Henchcliffe
1
Affiliations
1
Weill Cornell Parkinson's Disease and Movement Disorders Institute, Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
2
Division of Medical Ethics, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
PMID:
26981090
PMCID:
PMC4774238
DOI:
10.4103/1673-5374.169632
No abstract available